Wells Fargo raised the firm’s price target on Cardinal Health (CAH) to $136 from $135 and keeps an Equal Weight rating on the shares. The firm is also increasing its estimates following Q2 results to reflect modestly higher core earnings and the closing of the GIA acquisition.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAH: